Highly Efficient System To Deliver Taxanes into Tumor Cells: Docetaxel-Loaded Chitosan Oligomer Colloidal Carriers
- 19 July 2008
- journal article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 9 (8), 2186-2193
- https://doi.org/10.1021/bm800298u
Abstract
Chitosan (CS) colloidal carriers, which consist of an oily core and a CS coating, were developed to facilitate a controlled intracellular delivery of docetaxel. The systems presented a particle size of <200 nm and a positive surface charge. As shown by the flow cytometry analysis, fluorescent CS carriers were rapidly internalized by human tumor cells. Fluorescence was observed in more than 80% of MCF7 (human breast adenocarcinoma) and almost 100% of A549 (human lung carcinoma) cells when a 2 h treatment with fluorescent CS carriers was given. A total of 24 h after treatment, docetaxel-loaded CS carriers had an effect on cell proliferation that was significantly greater than that of free docetaxel. These results indicate that docetaxel remains fully active upon its encapsulation into the colloidal carriers and that these systems actively transport docetaxel into cancer cells and, thus, result in a significant increase in its antiproliferative effect.Keywords
This publication has 23 references indexed in Scilit:
- Nanotechnology and CancerAnnual Review of Medicine, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Alternative drug formulations of docetaxel: a reviewAnti-Cancer Drugs, 2007
- Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerAnnals of Oncology, 2006
- Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid TumorsPharmaceutical Research, 2006
- Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast CancerJournal of Clinical Oncology, 2005
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Role of Formulation Vehicles in Taxane PharmacologyInvestigational New Drugs, 2001
- Docetaxel: an Active New Drug for Treatment of Advanced Epithelial Ovarian CancerJNCI Journal of the National Cancer Institute, 1995
- Paclitaxel (Taxol)The New England Journal of Medicine, 1995